J. E. Davis Quest Diagnostics Inc (DGX) insider trading activity

J. E. Davis is CEO and President of QUEST DIAGNOSTICS INC. Currently has a direct ownership of 125,968 shares of DGX, which is worth approximately $17.3 Million. The most recent transaction as insider was on Feb 28, 2024, when has been sold 5,020 shares (Common Stock) at a price of $126.36 per share, resulting in proceeds of $634,327. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 126K

0% 3M change

22.74% 12M change

Total Value Held $17.3 Million

J. E. Davis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2024	SELL Payment of exercise price or tax liability	$634,327 $126.36 p/Share	5,020 Reduced 3.83%	125,968 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$815,755 $125.02 p/Share	6,525 Reduced 4.75%	130,988 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	$1,674,017 $125.02 p/Share	13,390 Added 8.87%	137,513 Common Stock
Feb 21 2024	SELL Payment of exercise price or tax liability	$95,265 $125.02 p/Share	762 Reduced 0.61%	124,123 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	22,251 Added 15.12%	124,885 Common Stock
Mar 06 2023	SELL Payment of exercise price or tax liability	$1,188,202 $147.86 p/Share	8,036 Reduced 7.26%	102,634 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	$2,248,063 $147.86 p/Share	15,204 Added 12.08%	110,670 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$181,771 $140.69 p/Share	1,292 Reduced 1.34%	95,466 Common Stock
Feb 23 2023	SELL Payment of exercise price or tax liability	$217,797 $147.86 p/Share	1,473 Reduced 1.82%	79,315 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	17,443 Added 15.27%	96,758 Common Stock
Nov 01 2022	BUY Grant, award, or other acquisition	-	13,980 Added 14.75%	80,788 Common Stock
Mar 07 2022	SELL Payment of exercise price or tax liability	$1,343,830 $130.09 p/Share	10,330 Reduced 13.39%	66,808 Common Stock
Mar 07 2022	BUY Grant, award, or other acquisition	$2,583,067 $130.09 p/Share	19,856 Added 20.47%	77,138 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	9,787 Added 14.59%	57,282 Common Stock
Feb 23 2022	SELL Payment of exercise price or tax liability	$317,070 $130.16 p/Share	2,436 Reduced 4.88%	47,495 Common Stock
Mar 09 2021	SELL Payment of exercise price or tax liability	$961,910 $115.42 p/Share	8,334 Reduced 14.3%	49,931 Common Stock
Mar 09 2021	BUY Grant, award, or other acquisition	$1,912,509 $115.42 p/Share	16,570 Added 22.14%	58,265 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$97,679 $121.19 p/Share	806 Reduced 1.9%	41,695 Common Stock
Feb 23 2021	SELL Payment of exercise price or tax liability	$151,438 $121.15 p/Share	1,250 Reduced 2.86%	42,501 Common Stock
Feb 17 2021	BUY Grant, award, or other acquisition	-	5,665 Added 11.46%	43,751 Common Stock

JED

J. E. Davis

CEO and President

Secaucus, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DGX shares.

Notify only if

Value

Insider Trading

Get notified when an Quest Diagnostics Inc insider buys or sells DGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to QUEST DIAGNOSTICS INC

Track Activities on DGX

Account